Back to calendar
Contineum Therapeutics, Inc. (CTNM) Earnings
CTNM reports earnings on Wednesday, November 11, 2026
earnings report
November 11, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.45
Actual EPS: $-0.40
EPS surprise: 10.87%
Company overview
Market Cap$622.6M
PriceUSD 16.55
EPS (TTM)-1.74
52-week high17.51
52-week low8.60
SectorHealth Technology
IndustryBiotechnology
Employees51